Australia’s PET imaging agents market to see 2% CAGR growth until 2033

The sector’s expansion is driven by a surge in prostate cancer cases.

Australia’s PET imaging agents market is projected to expand at a compound annual growth rate of 2% through 2033, said GlobalData.

The sector’s expansion is driven by a surge in prostate cancer cases, underscoring the rising need for early detection for improved patient outcomes.

Meanwhile, the country accounted for around 10% of the Asia-Pacific market in 2024.

This growth is attributed to the rising demand for next-generation imaging technologies and increased healthcare investments across the region.